Oncology News

Minister for Health James Reilly has said the salary and conditions of Director General of the HSE Tony O' Brien are perfectly in line with public pay policy.

IU Goshen Center for Cancer Care is using an advanced treatment called HIPEC which stands for Hyperthermic Intraperitoneal Chemotherapy.

Xiaowei Wang, PhD, and his colleagues have designed synthetic molecules that combine the advantages of two experimental RNA therapies against cancer.

The Triangle's two major cancer centers didn't make the list, but GlaxoSmithKline has lined up six other major global research institutions to collaborate on research into new ways to fight cancer using a mix of drugs.

Angiochem, a clinical stage biotechnology company developing drugs that are uniquely capable of crossing the blood-brain barrier , today announced that its lead oncology compound, ANG1005, a novel paclitaxel-peptide drug conjugate in development for breast cancer patients with brain metastasis and patients with primary brain cancer, and ANG4043, a ... (more)

Just 31% of the women with the disease survived for five years which was worse than poor nations like Bulgaria and Lithuania Research by The Lancet Oncology and analysed by the Daily Mirror found patients with the disease were more likely to die in the UK and Ireland than anywhere else in Europe.

To insert individual citation into a bibliography in a word-processor, select your preferred citation style below and drag-and-drop it into the document.

Cancer and blood disorder patients can now get faster care for their symptoms at an urgent care clinic that is now open in Winnipeg.

Florida-based Digital Blue Dog have signed an agreement to exclusively represent DBD's Oncology Network, creating the largest Oncology specific and patient-centric point-of-care network in the U.S. The two companies will still maintain operational independence while HMN will exclusively represent the combined network of nearly 15,000 high ... (more)

A sensitive new DNA test can predict how long ovarian cancer patients will survive, and guide personalized treatment decisions, according to new research.

Roche and Molecular Partners AG today announced that they have entered into a research collaboration and licensing agreement to discover, develop and commercialize several proprietary therapeutics incorporating Molecular Partners' DARPin A biologics conjugated to toxic agents developed at Roche for the treatment of cancer.

The meeting will be held The studies highlight Eisai's current and ongoing clinical research efforts with eribulin mesylate, and reinforce the Company's commitment to metastatic breast cancer.

Equity Profile Report expands its NASDAQ Active Stock Weekly Watch List adding OncoMed Pharmaceuticals, Inc. and Clovis Oncology, Inc. .

The affiliation agreement, if approved, aims to find ways for Ann Arbor-based University of Michigan Health System to work with Allegiance Health, which serves the Jackson area.

November was Lung Cancer Awareness Month, but you'd never know it. Consumers aren't bombarded by products in blue, the color designated by some to raise the profile of the disease.

Correspondence: Dr D Weisdorf, Division of Hematology-Oncology and Transplantation, Department of Medicine, University of Minnesota, 14-142 PWB, 516 Delaware, Street SE, Minneapolis, MN 55455, USA.

Minister of Health, John Boyce , noted that those cancers which were of particular public concern were cancers of the prostate, breast, cervix and colon which were attributable to premature deaths in persons under 65 years of age.

MEDIAN Technologies , a leading medical imaging software solutions developer and a service provider for image interpretation and management in oncology clinical trials and clinical routine, today announced it has signed a three-year collaborative agreement with South Texas Accelerated Research Therapeutics .

Wake Forest Baptist Medical Center's new Comprehensive Cancer Center, which will open to patients next week, represents a $125 million expansion.

Presage Biosciences is one company that hopes to pioneer this personalized and data-driven approach, which they call " precision oncology."